Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET

Cécile Tissot(Hirslanden Clinique des Grangettes), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Tharick A. Pascoal(Montreal Neurological Institute and Hospital), João Pedro Ferrari‐Souza(Universidade Federal do Rio Grande do Sul), Mira Chamoun(Douglas Mental Health University Institute), Joseph Therriault(Douglas Mental Health University Institute), Nicholas J. Ashton(King's College London), Kaj Blennow(Sahlgrenska University Hospital), Min Su Kang(Douglas Mental Health University Institute), Jaime Fernández Arias(Douglas Mental Health University Institute), Sulantha Mathotaarachchi(Montreal Neurological Institute and Hospital), Vanessa Pallen(McGill University), Nesrine Rahmouni(McGill University), Pâmela C.L. Ferreira(University of Pittsburgh), Andréa Lessa Benedet(University of Pittsburgh), Thomas K. Karikari(University of Pittsburgh), Peter Kunach(Southwestern Medical Center), Stijn Servaes(Douglas Mental Health University Institute), Firoza Z Lussier(McGill University), Eugeen Vanmechelen(ADx NeuroSciences), Henrik Zetterberg(University of Wisconsin–Madison), Gleb Bezgin(Montreal Neurological Institute and Hospital), Jenna Stevenson(McGill University), Dana Tudorascu(University of Pittsburgh), Nina Margherita Poltronetti(McGill University), Serge Gauthier(Texas Instruments (France))
EBioMedicine
February 1, 2022
Cited by 76


Related Papers